Overview


According to FutureWise analysis the market for cardiovascular and soft tissue repair patches in 2023 is US$ 4.48 billion, and is expected to reach US$ 8.69 billion by 2031 at a CAGR of 8.60%.

The increase in the incidence of cardiovascular and tissue regeneration surgeries has resulted in an underlying demand for the development of repair patches that can be applied to tissue regeneration and repair. It facilitates the repair of damaged tissue cells caused by underlying diseases or surgery. As a consequence of the outbreak, there has been an increase in the demand for medical supplies. The most commonly used medical devices in primary clinical care are respiratory support devices, such as atomizers, life support machines, oxygen generators, and monitors. A rise in hernia cases such as inguinal hernia and congenital diaphragmatic hernia and the resulting need for tissue repair patches are expected to positively impact the market for soft tissue repair patches.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cardiovascular And Soft Tissue Repair Patches Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cardiovascular And Soft Tissue Repair Patches Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Baxter
  • Admedus
  • Abbott
  • LeMaitre Vascular Inc.
  • Edwards Life Sciences Corporation
  • Glycar SA Pty. Ltd.
  • LabCor
  • Cryolife, Inc.
  • CorMatrix
  • Terumo Medical Corporation
  • Bard Peripheral Vascular Inc.
  • Neovasc
  • W.L. Gore and Associates, Inc.
  • B.Braun
  • Novomedics
  • TEI Biosciences Inc.
  • Perouse Medical
  • Gunze Limited
  • Atriummed
  • Maverick Bioscience
  • Southern Lights Biomaterials

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Application

  • Cardiac repair
    • Atrial septal defect
    • Common atrium
    • Defects of the endocardial cushion
    • Ventricular septal defect
    • Tetralogy of Fallot
    • Right ventricular outflow tract reconstruction
    • Suture bleeding
  • Vascular repair and reconstruction
    • Carotid endarterectomy
    • Anomalous connection of the pulmonary veins
    • Transposition of the Great Vessels
    • Reconstruction of portal and superior mesenteric veins
    • Other Vascular repair and reconstruction
  • Pericardial repair
  • Dural repair
  • Soft Tissue Repair
    • Defects of the abdominal wall
    • Defects of the thoracic wall
    • Gastric binding
    • Hernias

By Raw Materials

  • ePTFE
  • Biomaterial and tissue engineered material
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Cardiovascular And Soft Tissue Repair Patches Market By Application, By Raw Materials and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cardiovascular And Soft Tissue Repair Patches Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cardiovascular And Soft Tissue Repair Patches Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cardiovascular And Soft Tissue Repair Patches Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cardiovascular And Soft Tissue Repair Patches Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiac repair
         1.1. Atrial septal defect
         1.2. Common atrium
         1.3. Defects of the endocardial cushion
         1.4. Ventricular septal defect
         1.5. Tetralogy of Fallot
         1.6. Right ventricular outflow tract reconstruction
         1.7. Suture bleeding
        2. Vascular repair and reconstruction
         2.1. Carotid endarterectomy
         2.2. Anomalous connection of the pulmonary veins
         2.3. Transposition of the great vessels
         2.4. Reconstruction of portal and superior mesenteric veins
         2.5. Other Vascular repair and reconstruction
        3. Pericardial repair
        4. Dural repair
        5. Soft Tissue repair
         5.1. Defects of the abdominal wall
         5.2. Defects of the thoracic wall
         5.3. Gastric binding
         5.4. Hernias

  • 8.   Cardiovascular And Soft Tissue Repair Patches Market, By Raw Materials Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. ePTFE
        2. Biomaterial and tissue engineered material
        3. Others

  • 9.   North America Cardiovascular And Soft Tissue Repair Patches Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Cardiovascular And Soft Tissue Repair Patches Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Cardiovascular And Soft Tissue Repair Patches Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Cardiovascular And Soft Tissue Repair Patches Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •       1. Baxter
             1.1. Company Overview
             1.2. Product Portfolio
             1.3. SWOT Analysis
             1.4. Financial Overview
             1.5. Strategic Overview
            2. Admedus
             2.1. Company Overview
             2.2. Product Portfolio
             2.3. SWOT Analysis
             2.4. Financial Overview
             2.5. Strategic Overview
            3. Abbott
             3.1. Company Overview
             3.2. Product Portfolio
             3.3. SWOT Analysis
             3.4. Financial Overview
             3.5. Strategic Overview
            4. LeMaitre Vascular Inc.
             4.1. Company Overview
             4.2. Product Portfolio
             4.3. SWOT Analysis
             4.4. Financial Overview
             4.5. Strategic Overview
            5. Edwards Life Sciences Corporation
             5.1. Company Overview
             5.2. Product Portfolio
             5.3. SWOT Analysis
             5.4. Financial Overview
             5.5. Strategic Overview
            6. Glycar SA Pty. Ltd.
             6.1. Company Overview
             6.2. Product Portfolio
             6.3. SWOT Analysis
             6.4. Financial Overview
             6.5. Strategic Overview
            7. LabCor
             7.1. Company Overview
             7.2. Product Portfolio
             7.3. SWOT Analysis
             7.4. Financial Overview
             7.5. Strategic Overview
            8. Cryolife, Inc.
             8.1. Company Overview
             8.2. Product Portfolio
             8.3. SWOT Analysis
             8.4. Financial Overview
             8.5. Strategic Overview
            9. CorMatrix
             9.1. Company Overview
             9.2. Product Portfolio
             9.3. SWOT Analysis
             9.4. Financial Overview
             9.5. Strategic Overview
            10. Terumo Medical Corporation
             10.1. Company Overview
             10.2. Product Portfolio
             10.3. SWOT Analysis
             10.4. Financial Overview
             10.5. Strategic Overview
            11. Bard Peripheral Vascular Inc.
             11.1. Company Overview
             11.2. Product Portfolio
             11.3. SWOT Analysis
             11.4. Financial Overview
             11.5. Strategic Overview
            12. Neovasc
             12.1. Company Overview
             12.2. Product Portfolio
             12.3. SWOT Analysis
             12.4. Financial Overview
             12.5. Strategic Overview
            13. W.L. Gore and Associates, Inc.
             13.1. Company Overview
             13.2. Product Portfolio
             13.3. SWOT Analysis
             13.4. Financial Overview
             13.5. Strategic Overview
            14. B.Braun
             14.1. Company Overview
             14.2. Product Portfolio
             14.3. SWOT Analysis
             14.4. Financial Overview
             14.5. Strategic Overview
            15. Novomedics
             15.1. Company Overview
             15.2. Product Portfolio
             15.3. SWOT Analysis
             15.4. Financial Overview
             15.5. Strategic Overview
            16. TEI Biosciences Inc.
             16.1. Company Overview
             16.2. Product Portfolio
             16.3. SWOT Analysis
             16.4. Financial Overview
             16.5. Strategic Overview
            17. Perouse Medical
             17.1. Company Overview
             17.2. Product Portfolio
             17.3. SWOT Analysis
             17.4. Financial Overview
             17.5. Strategic Overview
            18. Gunze Limited
             18.1. Company Overview
             18.2. Product Portfolio
             18.3. SWOT Analysis
             18.4. Financial Overview
             18.5. Strategic Overview
            19. Atriummed
             19.1. Company Overview
             19.2. Product Portfolio
             19.3. SWOT Analysis
             19.4. Financial Overview
             19.5. Strategic Overview
            20. Maverick Bioscience
             20.1. Company Overview
             20.2. Product Portfolio
             20.3. SWOT Analysis
             20.4. Financial Overview
             20.5. Strategic Overview
            21. Southern Lights Biomaterials
             21.1. Company Overview
             21.2. Product Portfolio
             21.3. SWOT Analysis
             21.4. Financial Overview
             21.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients